The carpal tunnel syndrome. Clinical definite CTS with normal electrodiagnostic studies and diagnostic value sonography.
- Conditions
- tunnelsyndrome10034606
- Registration Number
- NL-OMON29793
- Lead Sponsor
- Canisius Wilhelmina Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 160
Paresthesia or pain in de area supplied by median nerve, with at least 2 of the following: nocturnal complaints, improvement by Flick's sign, worsening with handmovements.
Normal electrodiagnostic investigation of the median nerve.
Clinical polyneuropathy, Trauma, bad general condition with reduced life expectancy, severe atrophy of m. Abductor pollicis brevis, pregnancy, alcoholism,
arthritis of arthrosis, known diabetes mellitus, reumatoid arthritis, thyroid pathology, HNLPP, languagebarrier, psychiatric problem, other neurological problems in arm, former surgery, refusal surgery, age younger than 18, participance in other trials
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>A: Primairy outcome measure: the percentage of patients with no complaints<br /><br>after 6 months.<br /><br><br /><br>B: Primairy outcome measure: the percentage of patients with clinical definite<br /><br>and probable CTS with ultrasonography meeting the criteria of CTS. </p><br>
- Secondary Outcome Measures
Name Time Method <p>A: Secundairy outcome measures:<br /><br>1. The percentage of patients with an improvement of the Functional Status<br /><br>Score with 40 % or more after 6 months.<br /><br>2. The percentage of patients in group 2 who are operated on after 6 months.<br /><br>3. The percentage of patients in group 1 with persistent complaints of CTS.<br /><br>4. The percentage of patients with ultrasonography meeting the criteria of CTS.<br /><br><br /><br>B: Secundairy outcome measure:<br /><br>The correlation between nerve conduction studies and ultrasonography in<br /><br>patients with clinical definite and probable CTS.</p><br>